ACS strives to deliver indispensable chemistry-related information solutions to address global challenges and other issues facing the world’s scientific community. The Society is providing various resources to help improve the understanding of COVID-19 within the research community.
Cutting-edge research and news
R&D on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases, a report produced by CAS, a division of the American Chemical Society, available in the Society’s open access journal, ACS Central Science.
ACS joined other publishers in making all COVID-19 related published research freely and immediately available in the National Institutes of Health PubMed and is working to link from the World Health Organization (WHO) COVID-19 resource page to ACS published COVID-19 research
Custom Designed Solutions for Scientific Researchers from CAS. CAS is offering at no charge its considerable expertise to organizations investing their efforts toward vaccine and therapeutic research as they evaluate the means to combat COVID-19. Contact CAS Customer Center for more information.
Remote access for researchers
Demonstrations and tutorials of the ACS Publications’ platform.
Scientific presentations and laboratory safety
ACS Spring 2020 National Meeting & Expo posters and presentations via SciMeeting
Fostering chemical and laboratory safety across educational levels and the chemical enterprise
“Writing Grant Proposals and PRF Funding Opportunities for PUIs” on Tuesday April 28 at 2 p.m. Eastern Time.
ACS grants support research, education, and community projects